The headline is broadly defensible, but the qualifications matter. Effect sizes vary by population, the strongest claims rest on shorter trials, and credible voices push back on how it's typically framed.
that was joan at novartis at this time yes she joined our group in part to do this her real innovation beyond just the ideas that she figured out a way to test a medicine that could alter the biology of aging in humans and find an endpoint that's measurable and modifiable in a reasonable time frame which really is the achilles heel of aging research which is the ultimate outcome is virtually unmeasurable in the species of interest yes
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.
i decided i would take our rapamycin analog and i thought a organ system whose function i can change in a relatively short period of time is immune function so i decided let's do a trial and see if we give older adults an mtor inhibitor can we make their immune function better and the readout was a vaccine the response to a flu vaccine